142 related articles for article (PubMed ID: 1668107)
1. Effect of platelet-activating factor on tumor necrosis factor-induced superoxide generation from human neutrophils. Possible involvement of G proteins.
Braquet P; Hosford D; Koltz P; Guilbaud J; Paubert-Braquet M
Lipids; 1991 Dec; 26(12):1071-5. PubMed ID: 1668107
[TBL] [Abstract][Full Text] [Related]
2. Tumor necrosis factor alpha 'primes' the platelet-activating factor-induced superoxide production by human neutrophils: possible involvement of G proteins.
Paubert-Braquet M; Hosford D; Klotz P; Guilbaud J; Braquet P
J Lipid Mediat; 1990; 2 Suppl():S1-4. PubMed ID: 1966810
[TBL] [Abstract][Full Text] [Related]
3. Role of platelet-activating factor (PAF) in superoxide production by human polymorphonuclear leukocytes.
Takahashi S; Yoshikawa T; Naito Y; Tanigawa T; Yoshida N; Kondo M
Lipids; 1991 Dec; 26(12):1227-30. PubMed ID: 1668119
[TBL] [Abstract][Full Text] [Related]
4. Cooperation between tumor necrosis factor (TNF) and platelet-activating factor (PAF) in the inflammatory response.
Maestre C; Zarco P; Gómez-Guerrero C; González E; Herrero-Beaumont G; Braquet M; Egido J
J Lipid Mediat; 1990; 2 Suppl():S151-9. PubMed ID: 1966813
[TBL] [Abstract][Full Text] [Related]
5. Sensitization of human neutrophil defense activities through activation of platelet-activating factor receptors by ginkgolide B, a bioactive component of the Ginkgo biloba extract EGB 761.
Lenoir M; Pedruzzi E; Rais S; Drieu K; Perianin A
Biochem Pharmacol; 2002 Apr; 63(7):1241-9. PubMed ID: 11960600
[TBL] [Abstract][Full Text] [Related]
6. Action of platelet-activating factor (PAF) antagonists on the bronchopulmonary effects of PAF in the guinea-pig.
Pons F; Touvay C; Lejeune V; Carré C; Vilain B; Broquet C; Mencia-Huerta JM; Braquet P
J Lipid Mediat; 1989; 1(6):329-40. PubMed ID: 2519901
[TBL] [Abstract][Full Text] [Related]
7. Inhibition by BN 52021 (ginkgolide B) of the binding of [3H]-platelet-activating factor to human neutrophil granulocytes.
Földes-Filep E; Braquet P; Filep J
Biochem Biophys Res Commun; 1987 Nov; 148(3):1412-7. PubMed ID: 2825685
[TBL] [Abstract][Full Text] [Related]
8. Neutrophils accentuate renal cold ischemia-reperfusion injury. Dose-dependent protective effect of a platelet-activating factor receptor antagonist.
Riera M; Torras J; Herrero I; Valles J; Paubert-Braquet M; Cruzado JM; Alsina J; Grinyo JM
J Pharmacol Exp Ther; 1997 Feb; 280(2):786-94. PubMed ID: 9023292
[TBL] [Abstract][Full Text] [Related]
9. [Effect of BN52021 on platelet activating factor induced aggregation of psoriatic polymorphonuclear neutrophils].
Liu BJ; Zhang HT; Zheng MR
Zhonghua Yi Xue Za Zhi; 1994 Jun; 74(6):370-2, 392. PubMed ID: 7994650
[TBL] [Abstract][Full Text] [Related]
10. Reversible or irreversible modification of [3H]PAF binding on rabbit platelet membranes differentiates various PAF receptor antagonists.
Domingo MT; Piro F; Broquet C; Auclair E; Chabrier PE; Braquet P
Lipids; 1992 Aug; 27(8):582-6. PubMed ID: 1328798
[TBL] [Abstract][Full Text] [Related]
11. Platelet-leukocyte interaction in adhesion to endothelial cells induced by platelet-activating factor in vitro.
Hirafuji M; Shinoda H
Br J Pharmacol; 1991 Jun; 103(2):1333-8. PubMed ID: 1884095
[TBL] [Abstract][Full Text] [Related]
12. Stimulatory and inhibitory guanine-nucleotide-binding regulatory protein involvement in stimulation of arachidonic-acid release by N-formyl-methionyl-leucyl-phenylalanine and platelet-activating factor from guinea-pig alveolar macrophages. Differential receptor/G-protein interaction assessed by pertussis and cholera toxins.
Levistre R; Masliah J; Bereziat G
Eur J Biochem; 1993 Apr; 213(1):295-303. PubMed ID: 8386624
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of platelet-activating factor-induced retinal impairments by cholera and pertussis toxins.
Cluzel J; Doly M; Bazan NG; Bonhomme B; Braquet P
Ophthalmic Res; 1995; 27(3):153-7. PubMed ID: 8538992
[TBL] [Abstract][Full Text] [Related]
14. Cell adhesion by membrane-bound paf-acether.
Ninio E; Leyravaud S; Bidault J; Jurgens P; Benveniste J
Int Immunol; 1991 Nov; 3(11):1157-63. PubMed ID: 1760410
[TBL] [Abstract][Full Text] [Related]
15. Aggregation of human polymorphonuclear leukocytes by endothelin: role of platelet-activating factor.
Gómez-Garre D; Guerra M; González E; López-Farré A; Riesco A; Caramelo C; Escanero J; Egido J
Eur J Pharmacol; 1992 Dec; 224(2-3):167-72. PubMed ID: 1468506
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of platelet-activating factor (PAF)-induced chemotaxis and PAF binding to human eosinophils and neutrophils by the specific ginkgolide-derived PAF antagonist, BN 52021.
Kurihara K; Wardlaw AJ; Moqbel R; Kay AB
J Allergy Clin Immunol; 1989 Jan; 83(1):83-90. PubMed ID: 2536413
[TBL] [Abstract][Full Text] [Related]
17. The involvement of platelet-activating factor (PAF)-induced monocyte activation and tumor necrosis factor (TNF) production in shock.
Bonavida B; Paubert-Braquet M; Hosford D; Braquet P
Prog Clin Biol Res; 1989; 308():485-9. PubMed ID: 2780710
[No Abstract] [Full Text] [Related]
18. Biochemical events associated with the stimulation of rabbit neutrophils by platelet-activating factor.
Naccache PH; Molski MM; Volpi M; Shefcyk J; Molski TF; Loew L; Becker EL; Sha'afi RI
J Leukoc Biol; 1986 Nov; 40(5):533-48. PubMed ID: 3021882
[TBL] [Abstract][Full Text] [Related]
19. Activation of guinea pig eosinophils by human recombinant IL-5. Selective priming to platelet-activating factor-acether and interference of its antagonists.
Coëffier E; Joseph D; Vargaftig BB
J Immunol; 1991 Oct; 147(8):2595-602. PubMed ID: 1655895
[TBL] [Abstract][Full Text] [Related]
20. The contractile action of platelet-activating factor on gallbladder smooth muscle.
Parkman HP; James AN; Ryan JP
Am J Physiol Gastrointest Liver Physiol; 2000 Jul; 279(1):G67-72. PubMed ID: 10898747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
